Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1656 (LINC01656) is a lincRNA gene located on chromosome 22 in humans, and does not code for a protein[1][3]. Its transcript size is 630 bp, and it is annotated as strictly non-coding based on protein-coding potential analysis[3]. LINC01656 is catalogued in genomic and transcriptomic databases but, as of now, has no published functional studies or links to clear biological or pathological roles. It has been included as a locus in at least one GWAS for intergenic variants[5], but without demonstrated functional impact. LINC01656 is not recognized as a therapeutic target, druggable biomolecule, or clinical biomarker[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1656 (LINC01656).